BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29869044)

  • 1. Sparse Representation-Based Patient-Specific Diagnosis and Treatment for Esophageal Squamous Cell Carcinoma.
    Huang B; Zhong N; Xia L; Yu G; Cao H
    Bull Math Biol; 2018 Aug; 80(8):2124-2136. PubMed ID: 29869044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and translational advances in esophageal squamous cell carcinoma.
    Reichenbach ZW; Murray MG; Saxena R; Farkas D; Karassik EG; Klochkova A; Patel K; Tice C; Hall TM; Gang J; Parkman HP; Ward SJ; Tétreault MP; Whelan KA
    Adv Cancer Res; 2019; 144():95-135. PubMed ID: 31349905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Curated Target Gene Pool Assisting Early Disease Prediction and Patient-Specific Treatment for Small Cell Lung Cancer.
    Dong Y; Cao H; Liang Z
    J Comput Biol; 2018 Jun; 25(6):576-585. PubMed ID: 29741913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine.
    Yang JW; Choi YL
    Pathol Res Pract; 2017 Jul; 213(7):836-841. PubMed ID: 28554745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA and mRNA integration network reconstruction reveals novel key regulators in esophageal squamous-cell carcinoma.
    Alaei S; Sadeghi B; Najafi A; Masoudi-Nejad A
    Genomics; 2019 Jan; 111(1):76-89. PubMed ID: 29317304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A curated target gene pool assisting disease prediction and patient-specific biomarker selection for lung squamous cell carcinoma.
    Huang B; Zhong N; Cao H; Yu G
    Oncol Lett; 2018 Oct; 16(4):5140-5146. PubMed ID: 30197682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracking significant modules and key genes for esophageal squamous cell carcinoma based on differential modules.
    Zheng ML; Zhou NK; Luo CH
    J Cancer Res Ther; 2018 Dec; 14(Supplement):S1135-S1140. PubMed ID: 30539859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized and targeted therapy of esophageal squamous cell carcinoma: an update.
    Liu Y; Xiong Z; Beasley A; D'Amico T; Chen XL
    Ann N Y Acad Sci; 2016 Oct; 1381(1):66-73. PubMed ID: 27399176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cancer-array approach elucidates the immune escape mechanism and defects in the DNA repair system in esophageal squamous cell carcinoma.
    Dadkhah E; Naseh H; Farshchian M; Memar B; Sankian M; Bagheri R; Forghanifard MM; Montazer M; Kazemi Noughabi M; Hashemi M; Abbaszadegan MR
    Arch Iran Med; 2013 Aug; 16(8):463-70. PubMed ID: 23906251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
    Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
    Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cells in esophageal cancer and response to therapy.
    Harada K; Pool Pizzi M; Baba H; Shanbhag ND; Song S; Ajani JA
    Cancer; 2018 Oct; 124(20):3962-3964. PubMed ID: 30368777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of esophageal cancer pathway deviation and construction of a diagnosis model using three kernel genes.
    Xue W; Fan Z; Li L; Yan D; Shen Z; Zhai Y; Kan Q; Zhao J
    J Cell Physiol; 2019 Aug; 234(10):18098-18110. PubMed ID: 30835828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verrucous esophageal carcinoma is a unique indolent subtype of squamous cell carcinoma: a systematic review and individual patient regression analysis.
    Li DK; Haffar S; Horibe M; Homsi HA; Zukerberg L; Murad MH; Visrodia KH; Gala M; Katzka DA; Bazerbachi F
    J Gastroenterol; 2021 Jan; 56(1):12-24. PubMed ID: 33079233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge database assisted gene marker selection for chronic lymphocytic leukemia.
    Xiang X; Wang YP; Cao H; Zhang X
    J Int Med Res; 2018 Aug; 46(8):3358-3364. PubMed ID: 29996709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of chemotherapeutics for unresectable advanced esophageal cancer.
    Imazeki H; Kato K
    Expert Rev Anticancer Ther; 2020 Dec; 20(12):1083-1092. PubMed ID: 32820965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.
    Sasaki Y; Tamura M; Koyama R; Nakagaki T; Adachi Y; Tokino T
    World J Gastroenterol; 2016 Feb; 22(7):2284-93. PubMed ID: 26900290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma.
    Peng H; Wang S; Pang L; Yang L; Chen Y; Cui XB
    Mol Omics; 2019 Feb; 15(1):88-100. PubMed ID: 30706927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis of gene expression profiles of esophageal squamous cell carcinoma.
    He Y; Liu J; Zhao Z; Zhao H
    Dis Esophagus; 2017 May; 30(5):1-8. PubMed ID: 28375447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of disease-specific transcriptional regulatory networks identifies co-activation of four gene in esophageal squamous cell carcinoma.
    Zhao Y; Min L; Xu C; Shao L; Guo S; Cheng R; Xing J; Zhu S; Zhang S
    Oncol Rep; 2017 Jul; 38(1):411-417. PubMed ID: 28560409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Protein Interactome in Esophageal Squamous Cell Carcinoma Offers Novel Systems Biomarker Candidates with High Diagnostic and Prognostic Performance.
    Gulfidan G; Beklen H; Sinha I; Kucukalp F; Caloglu B; Esen I; Turanli B; Ayyildiz D; Arga KY; Sinha R
    OMICS; 2021 Aug; 25(8):495-512. PubMed ID: 34297901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.